Chikako Ohshima

Chikako Ohshima

Auto-generated profile, based on publicly available information

Chikako Ohshima

Institute of Natural Medicine, University of Toyama, Toyama, Japan

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2022 in Molecular Cancer Research
Verified
Journal Article
Closed access
PDF file
SUSisca Ucche
Sisca Ucche
SYSatoru Yokoyama
Satoru Yokoyama
MMMarija Mojic
Marija Mojic
KOKohei Oki
Kohei Oki
COChikako Ohshima
Chikako Ohshima
YHYoshihiro Hayakawa
Yoshihiro Hayakawa
Among factors involved in cancer cells escaping from immune responses, an intrinsic defect in the IFNγ response is considered to be one of the major players allowing cancer cells to evade the host immunity. In this study, we investigated how tumor cells escape from the IFNγ-dependent immune response through the immunoediting process by analyzing originally established immune-escape variants of melanoma cells. We found that the immune-escape melanoma variants gained resistance to the IFNγ-induced oxidative stress response and identified glutathione-S-transferase-4 (GSTA4) as a critical molecule in this process. Furthermore, the immune escape melanoma variants acquired a greater metastatic ability by a GSTA4-dependent mechanism. Implications: Considering the importance of GSTA4 in controlling IFNγ responsiveness and the metastatic potential of other melanoma cells, our results highlight a novel mechanism whereby cancer cells escape from host immunity and gain metastatic ability by acquiring resistance to oxidative stress responses through the upregulation of GSTA4.

3 April 2023
Verified
Other
Open access
SUSisca Ucche
Sisca Ucche
SYSatoru Yokoyama
Satoru Yokoyama
MMMarija Mojic
Marija Mojic
KOKohei Oki
Kohei Oki
COChikako Ohshima
Chikako Ohshima
YHYoshihiro Hayakawa
Yoshihiro Hayakawa
S1. Establishment of immune-escape variants of B16OVA cells S2. Immune-escape variants of B16OVA cells respond to IFN-gamma S3. Establishment of GSTA4 over-expressing B16OVA cells and GSTA4 knock-down IMM2 cells S4. Tumor-infiltrating T cell population in IMM2 shCTRL and IMM2 shGSTA4 tumors S5. Expression of GSTA4 in metastatic B16 melanoma variants

3 April 2023
Verified
Other
Open access
SUSisca Ucche
Sisca Ucche
SYSatoru Yokoyama
Satoru Yokoyama
MMMarija Mojic
Marija Mojic
KOKohei Oki
Kohei Oki
COChikako Ohshima
Chikako Ohshima
YHYoshihiro Hayakawa
Yoshihiro Hayakawa
S1. Establishment of immune-escape variants of B16OVA cells S2. Immune-escape variants of B16OVA cells respond to IFN-gamma S3. Establishment of GSTA4 over-expressing B16OVA cells and GSTA4 knock-down IMM2 cells S4. Tumor-infiltrating T cell population in IMM2 shCTRL and IMM2 shGSTA4 tumors S5. Expression of GSTA4 in metastatic B16 melanoma variants

27 November 2025
Verified
Other
Open access
PDF file
SUSisca Ucche
Sisca Ucche
SYSatoru Yokoyama
Satoru Yokoyama
MMMarija Mojic
Marija Mojic
KOKohei Oki
Kohei Oki
COChikako Ohshima
Chikako Ohshima
YHYoshihiro Hayakawa
Yoshihiro Hayakawa
S1. Establishment of immune-escape variants of B16OVA cells S2. Immune-escape variants of B16OVA cells respond to IFN-gamma S3. Establishment of GSTA4 over-expressing B16OVA cells and GSTA4 knock-down IMM2 cells S4. Tumor-infiltrating T cell population in IMM2 shCTRL and IMM2 shGSTA4 tumors S5. Expression of GSTA4 in metastatic B16 melanoma variants

3 April 2023
Verified
Other
Open access
SUSisca Ucche
Sisca Ucche
SYSatoru Yokoyama
Satoru Yokoyama
MMMarija Mojic
Marija Mojic
KOKohei Oki
Kohei Oki
COChikako Ohshima
Chikako Ohshima
YHYoshihiro Hayakawa
Yoshihiro Hayakawa
Among factors involved in cancer cells escaping from immune responses, an intrinsic defect in the IFNγ response is considered to be one of the major players allowing cancer cells to evade the host immunity. In this study, we investigated how tumor cells escape from the IFNγ-dependent immune response through the immunoediting process by analyzing originally established immune-escape variants of melanoma cells. We found that the immune-escape melanoma variants gained resistance to the IFNγ-induced oxidative stress response and identified glutathione-S-transferase-4 (GSTA4) as a critical molecule in this process. Furthermore, the immune escape melanoma variants acquired a greater metastatic ability by a GSTA4-dependent mechanism.Implications:Considering the importance of GSTA4 in controlling IFNγ responsiveness and the metastatic potential of other melanoma cells, our results highlight a novel mechanism whereby cancer cells escape from host immunity and gain metastatic ability by acquiring resistance to oxidative stress responses through the upregulation of GSTA4.

27 November 2025
Verified
Other
Open access
SUSisca Ucche
Sisca Ucche
SYSatoru Yokoyama
Satoru Yokoyama
MMMarija Mojic
Marija Mojic
KOKohei Oki
Kohei Oki
COChikako Ohshima
Chikako Ohshima
YHYoshihiro Hayakawa
Yoshihiro Hayakawa
Among factors involved in cancer cells escaping from immune responses, an intrinsic defect in the IFNγ response is considered to be one of the major players allowing cancer cells to evade the host immunity. In this study, we investigated how tumor cells escape from the IFNγ-dependent immune response through the immunoediting process by analyzing originally established immune-escape variants of melanoma cells. We found that the immune-escape melanoma variants gained resistance to the IFNγ-induced oxidative stress response and identified glutathione-S-transferase-4 (GSTA4) as a critical molecule in this process. Furthermore, the immune escape melanoma variants acquired a greater metastatic ability by a GSTA4-dependent mechanism.Implications:Considering the importance of GSTA4 in controlling IFNγ responsiveness and the metastatic potential of other melanoma cells, our results highlight a novel mechanism whereby cancer cells escape from host immunity and gain metastatic ability by acquiring resistance to oxidative stress responses through the upregulation of GSTA4.